Capstan Therapeutics, a biotechnology startup developing medicines that reprogram cells inside the body, has...

The executives behind autoimmune drug developer Prometheus Biosciences are back, armed with more than...

Listen to the article 3 min This audio is auto-generated. Please let us know...

Dive Brief: Thermo Fisher Scientific said Wednesday that it has partnered with Bayer to...

Listen to the article 3 min This audio is auto-generated. Please let us know...

Dive Brief: The Food and Drug Administration on Thursday approved a first-of-its-kind drug for...

Cancer immunotherapy developer NextCure is laying off 37% of its staff and streamlining its...

An autoimmune disease drug from Roche and Chugai Pharmaceutical hit its main goal in...

Dive Brief: Orchard Therapeutics said Wednesday it will offer a new gene therapy to...

A young biotechnology company plans to move an experimental medicine for a rare eye...

Dive Brief: Orchard Therapeutics on Monday won Food and Drug Administration approval for the...

Dive Brief: Bayer on Tuesday said it plans to seek regulatory approval of a...

Ask a healthcare professional (HCP), and chances are good that they’d like an easy...

Gene therapy developer Bluebird bio has raised a large debt financing in a bid...

Dive Brief: Tubulis, a German biotechnology startup developing antibody-drug conjugates, brought in €128 million,...

Asgard Therapeutics has become the latest emerging developer of “in vivo” cell therapies to...

Dive Brief: AstraZeneca is bolstering its rare disease division with the purchase of Amolyt...

The first drug for metabolic dysfunction-associated steatohepatitis will cost $47,400 per year, its developer,...

Advisers to the Food and Drug Administration have endorsed the use of two cellular...

Dive Brief: For the first time, the Food and Drug Administration has approved a...

The Food and Drug Administration has approved the first medicine for a common liver...

Dive Brief: The Biotechnology Innovation Organization on Wednesday backed legislation aiming to limit the...

Dive Brief: Merck on Wednesday announced plans to start clinical trials testing a newer...

Two cellular medicines for multiple myeloma were associated with an increased risk of early...

Allogene Therapeutics is turning to gene editing startup Arbor Biotechnologies for help developing “off-the-shelf”...

For Rick Bedlack, director of the ALS clinic at Duke University, tough times come...

Dive Brief: Roche’s experimental Alzheimer’s disease drug trontinemab showed “best-in-class” potential based on its...

Rare diseases, once a miniscule chapter in the pharma playbook, have become a major...

Dive Brief: President Biden is taking on a bipartisan bogeyman ahead of a critical...

Dive Brief: An experimental pill developed by Novo Nordisk helped obese people lose 13%...

Cigna is moving to limit how much health insurance providers and employers have to...

Dive Brief: The Food and Drug Administration is delaying an approval decision on Eli...

The Food and Drug Administration has expanded the label for Novo Nordisk’s fast-selling weight...

A large clinical trial meant to confirm the benefits of a new ALS medication...

A Boston-based biotechnology company on Thursday said its most advanced drug showed positive effects...

Boundless Bio, an oncology startup backed by Bayer and Arch Venture Partners, on Wednesday...

Dive Brief: Barcelona-based venture capital firm Invivo Partners is preparing to close an expected...

Dive Brief: Sionna Therapeutics, a Waltham, Massachusetts biotechnology startup, announced Wednesday it raised a...

Dive Brief: An experimental RNA-based medicine developed by Alnylam Pharmaceuticals, when added to standard...

After more than two years in the doldrums, initial public offerings, an important indicator...

Investors have poured $62 million into a biotechnology startup developing a drug to treat...

Dive Brief: The effects of an experimental medicine for a common liver disease strengthened...

Dive Brief: Abingworth, a venture capital group owned by Carlyle, will invest as much...

A good track record can be valuable in the uncertain and risky world of...

Advisers to the Centers for Disease Control and Prevention are weighing updates to their...

Dive Brief: Cancer drug developer FogPharma has raised $145 million in fresh funding, the...

Pfizer believes the answer to its sliding valuation lies in oncology.  The company, which...

Gritstone Bio will lay off about 40% of its workforce after missing out on...

Kenai Therapeutics, a San Diego-based biotechnology company, has raised $82 million to support its...

Dive Brief: ObsEva, a women’s health drug developer, on Wednesday said it plans to...

An Australian-based biotechnology company says a mid-stage clinical trial has shown that psilocybin, a...

Ginkgo Bioworks has acquired a biotechnology startup co-founded by gene editing pioneer Feng Zhang,...

Dive Brief: An experimental weight loss drug developed by Viking Therapeutics helped overweight and...

Dive Brief: GSK said Monday that its oral antibiotic succeeded in a late-stage trial in...

Dive Brief: The Food and Drug Administration on Saturday approved Alvotech and Teva Pharmaceuticals’...

The creativity and expertise of the researchers, technicians and assistants working in healthcare and...

ORI Capital, the China- and U.S.-based venture investor behind the biotechnology sector’s largest initial...

Dive Brief: Novavax will pay as much as $475 million to settle a dispute...

Dive Brief: Moderna shares rose by as much as 10% Thursday morning after the...

Dive Brief: BioMarin Pharmaceutical is struggling to sell the first marketed gene therapy for...

Dive Brief: The European Medicine Agency’s main drug review committee on Friday supported expanding...

The Biden Administration, through the Advanced Research Projects Agency for Health, has committed to...

Biotechnology startup Frontier Medicines has pulled in $80 million in new funding to support...

Infectious disease drug developer Vir Biotechnology on Tuesday disclosed that chief medical officer Phil...

A new research paper offers the most thorough look yet at a study that...

Dive Brief: AstraZeneca’s targeted cancer therapy Tagrisso can now be used alongside chemotherapy to...

Dive Brief: Shares of Rapt Therapeutics fell sharply Tuesday after the company disclosed U.S....

Lisa Benincosa is senior vice president of clinical pharmacology strategy at the specialized Clinical...

Dive Brief: The Food and Drug Administration has approved a new regimen for pancreatic...

Dive Brief: Aurinia Pharmaceuticals will restructure its operations and give money back to shareholders...

Astellas Pharma is delving deeper into cell therapies for cancer, announcing Thursday a research...

Gilead Sciences is evaluating the future of a cancer drug acquired in a multibillion-dollar...

Dive Brief: The Food and Drug Administration will decide by June 21 whether to...

Dive Brief: An experimental drug being developed by Denali Therapeutics and partner Sanofi for...

Intellia Therapeutics will work with a private biotechnology company to develop genetic medicines for...

Dive Brief: Alnylam Pharmaceuticals is delaying the readout of a closely watched Phase 3...

Dive Brief: Firefly Bio, a startup working to develop a new kind of cancer...

Sage Therapeutics said its new medicine, the first oral treatment for postpartum depression, is...

A little over four years ago, biotechnology giant Amgen retreated from neuroscience research, halting...

Dive Brief: Biotechnology startup BioAge Labs has raised $170 million to support an experimental...

As the venture arm of Alphabet, GV can be thought of as a technology...

Six biotechnology startups are merging into a new skin drug developer called Alys Pharmaceuticals,...

As life sciences and pharma services companies forge ahead in 2024, they find themselves...

Amgen is a global pharmaceutical company worth more than $160 billion. Nine of its...

BioNTech will pay $50 million and make a $200 million investment in Autolus Therapeutics...

Dive Brief: Neurona Therapeutics, a San Francisco-based biotechnology company, has raised another $120 million...

Biotechnology initial public offerings are showing sustained signs of life for the first time...

Takeda Pharmaceutical plans to quickly begin late-stage testing of an experimental drug for narcolepsy,...

Dive Brief: Metagenomi, a gene editing startup spun out of research at the University...

The CEOs of three major drugmakers defended the prices they charge U.S. patients in...

Dive Brief: Kyverna Therapeutics raised $319 million in a larger-than-expected initial public offering Thursday,...

Dive Brief: BridgeBio Pharma is selling partial rights to an experimental drug for a...

Dive Brief: Scion Life Sciences on Wednesday made its debut as a venture firm,...

Sales of Eli Lilly’s diabetes drug Mounjaro exceeded $5 billion in 2023, its first...

To hear venture capitalist Alex Morgan tell it, investors shouldn’t be in the business...

Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, will buy contract manufacturer...

In 2021, the Food and Drug Administration for the first time approved a medicine...

Dive Brief: The gene therapy company Avrobio agreed to a reverse merger with startup...

Roche is reshaping its early-stage pipeline of experimental drugs, jettisoning eight drug candidates in...

Dive Brief: Protagonist Therapeutics, a biotechnology company focused on peptide drugs, is teaming up...

Merck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its...

Arch Venture Partners, one of the biotechnology sector’s most prolific company creators, is raising...

Another biotechnology company has hit Wall Street via an initial public offering, the third...

Nestlé veteran François-Xavier Roger will succeed Sanofi chief financial officer Jean-Baptiste Chasseloup de Chatillon...

The U.S. government will test whether centrally coordinating insurance coverage can help people with...

GSK on Wednesday reported higher-than-expected sales of its RSV vaccine Arexvy, providing further evidence...

Dive Brief: Biotechnology startup Cour Pharmaceuticals has raised $105 million to advance a portfolio...

Dive Brief: Gilead has bought a bigger stake in cancer drug developer Arcus Biosciences,...

The clue came, as they often do, from an unexpected source. Some sixteen months...

Dive Brief: An experimental, under-the-skin shot of Bristol Myers Squibb’s immunotherapy Opdivo appeared to...

Johnson & Johnson CEO Joaquin Duato sold 2023 as a “remarkable year” on an...

Dive Brief: Novo Nordisk is adding yet another prospect to its obesity drug pipeline,...

After a rocky year that featured a restructuring, job cuts and the resignation of...

Radiopharmaceutical drugmaker RayzeBio drew interest from two other large drugmakers before agreeing to a...

European authorities are set to rescind the approval of a Duchenne muscular dystrophy drug...

Dive Brief: Bristol Myers Squibb’s cell therapy for multiple myeloma, Abecma, should be approved...

Dive Brief: ArriVent Biopharma is the second biotechnology company to go public this year,...

The Food and Drug Administration this week convened a group of experts to discuss...

Cancer drug developer CG Oncology has raised $380 million in an initial public offering than...

An 11-year-old boy who was born deaf can hear after receiving an experimental gene...

Sanofi on Tuesday said it will acquire San Diego biotechnology company Inhibrx in a...

Dive Brief: The makers of CAR-T cell therapies will need to warn about the...

Dive Brief: Coherus Biosciences on Monday said it has agreed to sell its approved...

Dive Brief: Gilead Sciences on Monday said its cancer drug Trodelvy missed the main...

As part of a makeover promised last year, Bayer is beginning a process of...

BridgeBio Pharma has agreed to sell future royalties on an experimental rare disease drug...

Five years ago this month, Takeda Pharmaceuticals completed a $62 billion acquisition of Shire...

Biotechnology company Ikena Oncology on Thursday said it would lay off staff and reallocate...

A Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck &...

A radiopharmaceutical drug from Novartis kept a rare type of neuroendocrine cancer at bay...

Jaguar Gene Therapy is spinning out part of its business to handle the specialized...

Mirae Asset Capital Life Science, a new venture capital fund, launched on Thursday, joining...

Dive Brief: Kyverna Therapeutics on Tuesday revealed plans to go public, testing the waters...

Dive Brief: Massachusetts-based startup Comanche BioPharma has raised $75 million in new venture funding...

The Food and Drug Administration on Tuesday approved Vertex Pharmaceuticals’ CRISPR-based medicine Casgevy for...

Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024....

The mood shifts on the third day of the J.P. Morgan Healthcare Conference. Deals...

The J.P. Morgan Healthcare Conference, a yearly temperature taker for the biotechnology industry, had...

Dive Brief: The use of GLP-1-based drugs to treat obesity and diabetes has no...

Chris Gibson, the CEO of Recursion Pharmaceuticals, thinks the future of drug discovery lies...

A group of high-profile scientists and billionaire financiers are building a new biomedical research...

European regulators will seek outside advice before making a decision on approval of Eisai...

Dive Brief: The number and amount of biotechnology financings dipped in 2023, with venture...

The arrival of powerful new drugs for obesity has reshaped the pharmaceutical industry, transforming...

Over the span of five months, biotechnology startup Aiolos Bio launched, raised initial funding...

Biotechnology’s embrace of artificial intelligence was never more literal than Tuesday at the J.P....

For the first time, the Food and Drug Administration has authorized a U.S. state...

A California-based company has raised tens of millions of dollars to support its mission...

CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of...

Dive Brief: Eli Lilly wants to make it easier for people to access its...

Dive Brief: Canada’s health regulators have approved Pfizer’s gene therapy for hemophilia B, the...

The Food and Drug Administration closed out 2023 with rejections of three drugmaker applications...

Dive Brief: Swiss pharmaceutical company Novartis has formed a new collaboration with partner Voyager...

A non-addictive pain pill faces its definitive test, while study results in ALS, a...

Merit Cudkowicz has spent her career treating some of the most unforgiving illnesses. She’s...

Dive Brief: Sanofi will stop developing one of its top cancer drug prospects after...

Dive Brief: Weeks after installing a new CEO, BioMarin Pharmaceutical is overhauling oversight of...

Dive Brief: The Food and Drug Administration on Thursday approved a new medicine for...

Bristol Myers Squibb has agreed to acquire Karuna Therapeutics for $14 billion, betting that...

Sarepta Therapeutics has asked the Food and Drug Administration to expand approval of its...

Dive Brief: Gene therapy developer MeiraGTx is selling its remaining financial interest in an...

Dive Brief: Clene Nanomedicine on Thursday said the Food and Drug Administration doesn’t believe...

Dive Brief: Argenx lost a quarter of its value Wednesday after reporting the second...

Dive Brief: GSK is deepening its investment in cancer treatments called antibody-drug conjugates, announcing...

Dive Brief: The European Commission has revoked the approvals for five generic versions of...

Dive Brief: Shares of UniQure dipped more than 10% Tuesday morning after the biotechnology...

Dive Brief: The Novo Nordisk Foundation, which owns a controlling stake in drugmaker Novo...

Dive Brief: Venture capital group Pivotal Life Sciences has raised its second fund, securing...

Dive Brief: Vir Biotechnology on Thursday announced a restructuring that will result in a...

Amgen has a new top scientist, announcing Thursday the appointment of Novartis veteran and...

The committee that recommends whether drugs should be approved in Europe has thrown its...

Dive Brief: The Food and Drug Administration on Thursday broadened use of a drug...